Ampio Pharm Stock Return On Equity
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
Ampio Pharm fundamentals help investors to digest information that contributes to Ampio Pharm's financial success or failures. It also enables traders to predict the movement of Ampio Pink Sheet. The fundamental analysis module provides a way to measure Ampio Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ampio Pharm pink sheet.
Ampio |
Ampio Pharm Company Return On Equity Analysis
Ampio Pharm's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Ampio Pharm Return On Equity | -1.14 |
Most of Ampio Pharm's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ampio Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Ampio Pharm has a Return On Equity of -1.1396. This is 95.25% lower than that of the Pharmaceuticals sector and 96.87% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Ampio Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ampio Pharm's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics of similar companies.Ampio Pharm is currently under evaluation in return on equity category among its peers.
Ampio Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.62 | ||||
| Current Valuation | (3.33 M) | ||||
| Shares Outstanding | 1.14 M | ||||
| Shares Owned By Insiders | 1.56 % | ||||
| Shares Owned By Institutions | 4.19 % | ||||
| Number Of Shares Shorted | 32.9 K | ||||
| Price To Earning | 28.57 X | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.63 M) | ||||
| Net Income | (8.63 M) | ||||
| Cash And Equivalents | 23.25 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 274 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 4.03 X | ||||
| Cash Flow From Operations | (8.56 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (10.66) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.95 | ||||
| Market Capitalization | 340.61 K | ||||
| Total Asset | 5.74 M | ||||
| Retained Earnings | (242.53 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 29.23 M | ||||
| Current Liabilities | 5.52 M | ||||
| Net Asset | 5.74 M |
About Ampio Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |